Skip to main content
NCBI home page
Springer logoLink to Springer
. 2017 Nov 26;9(3):317. doi: 10.1007/s12975-017-0589-4

Correction to: Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats

Tomoya Kinouchi 1,✉, Keiko T Kitazato 1, Kenji Shimada 1, Kenji Yagi 1, Yoshiteru Tada 1, Nobuhisa Matsushita 1, Yoshitaka Kurashiki 1, Junichiro Satomi 1, Masataka Sata 2, Shinji Nagahiro 1
PMCID: PMC6828375  PMID: 29177991

Correction to: Transl. Stroke Res. (2017)

10.1007/s12975-017-0577-8

In the original publication of the article, the second author (Keiko T. Kitazato) was missing.

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1007/s12975-017-0577-8

Articles from Translational Stroke Research are provided here courtesy of Springer

RESOURCES